Green Vision Biotechnology Quick Ratio (GVBT) starting from the second quarter 2022 to second quarter 2021, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Green Vision Biotechnology Corp.  (GVBT)

Green Vision Biotechnology's Quick Ratio

GVBT's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Regardless of the sequential decrease in Current Liabilities, during the second quarter 2022, Quick Ratio deteriorated to 0 a new company low.

Within Agricultural Production industry 55 other companies have achieved higher Quick Ratio than Green Vision Biotechnology in second quarter 2022. While Quick Ratio total ranking in the second quarter 2022 has deteriorated compared to the prior quarter from 6121 to 6785.

Explain Quick Ratio?
How much Cash & cash equivalents GVBT´s has?
What are GVBT´s Current Liabilities?




API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/GVBT/financial-strength
https://api.csimarket.com/api/v1/companies/GVBT/fundamentals
https://api.csimarket.com/api/v1/companies/GVBT/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
GVBT Quick Ratio (Jun 30 2022)
Q2
(Mar 31 2022)
Q1
(Dec 31 2021)
Q4
(Sep 30 2021)
Q3
(Jun 30 2021)
Q2
Y / Y Current Liabilities Change -0.82 %
Y / Y Cash & cash equivalent Change -87.46 %
Quick Ratio MRQ 0
GVBT's Total Ranking # 6785
Seq. Current Liabilities Change -2.35 %
Seq. Cash & cash equivalent Change 47.79 %



Quick Ratio second quarter 2022 Company Ranking
Within: No.
Agricultural Production Industry # 56
Consumer Non Cyclical Sector # 251
Overall Market # 6785


Quick Ratio Statistics
High Average Low
4.14 0.33 0
(Jan 31 2013)   (Dec 31 2021)




Financial Statements
Green Vision Biotechnology's Current Liabilities $ 11 Millions Visit GVBT's Balance sheet
Green Vision Biotechnology's Cash & cash equivalent $ 0 Millions Visit GVBT's Balance sheet
Source of GVBT's Sales Visit GVBT's Sales by Geography


Cumulative Green Vision Biotechnology's Quick Ratio

GVBT's Quick Ratio for the trailling 12 Months

GVBT Quick Ratio

(Jun 30 2022)
12 Months
(Mar 31 2022)
12 Months
(Dec 31 2021)
12 Months
(Sep 30 2021)
12 Months
(Jun 30 2021)
12 Months
Y / Y Current Liabilities TTM Growth 2.62 %
Y / Y Cash & cash equivalent TTM Growth -84.85 %
Quick Ratio TTM 0
Total Ranking TTM # 5894
Seq. Current Liabilities TTM Growth -0.2 %
Seq. Cash & cash equivalent TTM Growth -63.79 %


On the trailing twelve months basis In spite of the year on year decrease in GVBT's Current Liabilities to $10.66 millions, cumulative Quick Ratio